India to Chile: Imipenem Export Trade Route

The India to Chile Imipenem corridor is one of India's established pharmaceutical export routes, with 14 shipments documented worth a combined $1.5M USD. The route is dominated by VENUS REMEDIES LIMITED, which alone accounts for roughly 77% of all export value, reflecting the consolidated nature of India's imipenem manufacturing sector.

Across 5 active suppliers, the average shipment value stands at $105.7K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 77% of all shipments, consistent with imipenem's non-urgent bulk-order profile.

Shipment activity peaks during October–December, with an average transit time of 27 days port-to-port. The route has recorded an annual growth rate of 34.2%, placing it at rank #15 among India's top imipenem export destinations globally.

On the import side, key buyers of Indian imipenem in Chile include ASCEND LABORATORIES SPA AVENIDA APOQUINDO, A L SPA,, IND. Y COM. BAXTER DE CHILE LTDA. and 4 others. ASCEND LABORATORIES SPA AVENIDA APOQUINDO is the single largest importer with 3 shipments valued at $719.0K USD.

India's imipenem exports to Chile are driven primarily by a handful of large-scale manufacturers. VENUS REMEDIES LIMITED with 6 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 5 active exporters signals a competitive but concentrated market — buyers in Chile benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — VENUS REMEDIES LIMITED, BAXTER PHARMACEUTICALS INDIA PRIVATE LIMITED, VENUS REMEDIES LTD — together account for 98% of total trade value on this route. The average shipment value of $105.7K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.

Beyond the primary product category, shipments on this route include closely related formulations such as impracid 500 mg imipenem/cilastatin powder for injectable solution 500mg/500mg b.no.x3fb063e manufacturing .dt.06/2023exp.dt.0 and impracid 500 mg imipenem/cilastatin powder for injectable solution 500 mg/500 mgb.no.x3gb083ax3gb093ax3gb103ax3gb11, suggesting that buyers in Chile tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, ASCEND LABORATORIES SPA AVENIDA APOQUINDO is the largest importer with 3 shipments worth $719.0K USD — representing 49% of all imipenem imports from India on this route. A total of 7 buyers are active on this corridor.